The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of derazantinib (DZB) in patients with metastatic urothelial carcinoma (mUC) with activating FGFR1/2/3 genetic aberrations (GA): Results from the phase 1b/2 FIDES-02 study.
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Tilman Todenhöfer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb/Sanofi; Janssen; Merck Serono; MSD Oncology; Pfizer; Roche; Sanofi/Aventis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Basilea (Inst); Bayer (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); RhoVac (Inst)
 
Jean-Laurent Deville
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD Oncology
Consulting or Advisory Role - Janssen Oncology
 
Manuel Häckl
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Michalina Marszewska
Employment - Basilea Pharmaceutical
 
Phil McKernan
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Mikael Saulay
Employment - Basilea
 
Marc Engelhardt
Employment - Basilea
 
Maria De Santis
Honoraria - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Exelixis/Ipsen; Ferring; Gilead Sciences; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen
Consulting or Advisory Role - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Ferring; Gilead Sciences; GlaxoSmithKline; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Roche; Roche/Genentech; Sanofi